2019
DOI: 10.1007/s00134-019-05761-4
|View full text |Cite
|
Sign up to set email alerts
|

Hyperoxia during cardiopulmonary bypass does not decrease cardiovascular complications following cardiac surgery: the CARDIOX randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 28 publications
2
20
0
Order By: Relevance
“…In fact, a series of recent larger studies has demonstrated that lower oxygen targets could be applied safely during CPB without detrimental cardiac and renal outcomes. 16,17,36 Our findings are in congruence with a large retrospective study of 1,018 patients having cardiac surgery with CPB that failed to demonstrate a relationship between arterial hyperoxia and neurocognitive function 6 weeks after surgery. 18 Our study did not find any significant differences in adverse outcomes with the use of a lower oxygenation target, although interpretation of these results in support of the safety of a lower oxygenation target must be made with caution.…”
Section: Intraoperative Oxygen and Cognition After Surgerysupporting
confidence: 85%
See 1 more Smart Citation
“…In fact, a series of recent larger studies has demonstrated that lower oxygen targets could be applied safely during CPB without detrimental cardiac and renal outcomes. 16,17,36 Our findings are in congruence with a large retrospective study of 1,018 patients having cardiac surgery with CPB that failed to demonstrate a relationship between arterial hyperoxia and neurocognitive function 6 weeks after surgery. 18 Our study did not find any significant differences in adverse outcomes with the use of a lower oxygenation target, although interpretation of these results in support of the safety of a lower oxygenation target must be made with caution.…”
Section: Intraoperative Oxygen and Cognition After Surgerysupporting
confidence: 85%
“…In interpreting these results, it is entirely plausible that the arterial oxygen content is a minor variable in the response to ischemia-reperfusion injury, dwarfed by that from the systemic inflammatory response to CPB. Other studies both in cardiac surgery 16,17,36 and allied specialties have not demonstrated statistically significant results regarding the detrimental effects of hyperoxia, albeit via varied outcome measurements. 12,[37][38][39] It must be borne in mind that this was a study of moderate compared with severe hyperoxia.…”
Section: Intraoperative Oxygen and Cognition After Surgerymentioning
confidence: 93%
“…Cardiopulmponary bypass was standardised and comprise a heart-lung machine (Stockert Sorin S5, Heart Lung, Milan, Italy) with a target blood flow of 2.4 l/minutes per m 2 . [ 16 , 17 ] The mean arterial blood pressure (MAP) was maintained at more than 65 mm Hg by increasing the pump flow rate or, if required, by administering a bolus of phenylephrine (100 μg) or norepinephrine (5 μg). The pump primes for the CPB circuit contained 1500 ml of crystalloids (Plasma-Lyte; Baxter, Lessines, Belgium) and 5000 UI of heparin.…”
Section: Methodsmentioning
confidence: 99%
“…Premedication (alprazolam) was administered at the patient's request on the day before and the day of surgery. Cardiopulmonary bypass management was standardized for all patients as previously described [16][17][18] . Patient monitoring during anesthesia comprised continuous measurement of invasive blood, heart rate, oxygen saturation (SpO 2 ), central venous pressure, hypnosis (bispectral analysis (BIS XP monitor, Medtronic, France)), bladder temperature, diuresis, neuromuscular monitoring (NMT), and inspired/expired fraction of carbon dioxide and oxygen.…”
mentioning
confidence: 99%
“…Patient monitoring during anesthesia comprised continuous measurement of invasive blood, heart rate, oxygen saturation (SpO 2 ), central venous pressure, hypnosis (bispectral analysis (BIS XP monitor, Medtronic, France)), bladder temperature, diuresis, neuromuscular monitoring (NMT), and inspired/expired fraction of carbon dioxide and oxygen. Anesthesia induction was performed with propofol (Schnider model) and sufentanyl (Gepts model) administered by effect-site target-controlled infusion (Base Primea; Fresenius-Kabi, Germany) 16 . Propofol initial effect-site target concentration (Ce) was set at 4 μg/ml.…”
mentioning
confidence: 99%